Literature DB >> 10694238

Differential actions of L-cysteine on responses to nitric oxide, nitroxyl anions and EDRF in the rat aorta.

A Ellis1, C G Li, M J Rand.   

Abstract

1. The effects of L-cysteine were tested in rat aortic rings on responses to nitric oxide free radical (NO(*)), nitroxyl (NO(-)) derived from Angeli's salt and endothelium-derived relaxing factor (EDRF) activated by acetylcholine, ATP and the calcium ionophore A23187. Concentrations of 300 microM or less of L-cysteine had no effect on responses. 2. Relaxations produced by exogenous NO(*) (0.25 - 2.5 microM) were markedly prolonged and relaxations produced by sodium nitroprusside (0.001 - 0.3 microM) were enhanced by 1 and 3 mM L-cysteine. The enhancements by L-cysteine of responses to NO(*) and sodium nitroprusside may be attributed to the formation of S-nitrosocysteine. 3. Relaxations mediated by the nitroxyl anion (0.3 microM) donated from Angeli's salt were more prolonged than those produced by NO(*), and nitroxyl-induced relaxations were reduced by L-cysteine (1 and 3 mM). 4. EDRF-mediated relaxations produced by acetylcholine (0.01 - 10 microM), ATP (3 - 100 microM) and the calcium ionophore A23187 (0.1 microM) were significantly reduced by 3 mM L-cysteine. 5. The similarity between the inhibitory effects of L-cystei on responses to EDRF and on those to nitroxyl suggests that a component of the response to EDRF may be mediated by nitroxyl anion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10694238      PMCID: PMC1571842          DOI: 10.1038/sj.bjp.0703058

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  41 in total

1.  Comparison of the redox forms of nitrogen monoxide with the nitrergic transmitter in the rat anococcygeus muscle.

Authors:  C G Li; J Karagiannis; M J Rand
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

2.  Anion exchange resins discriminate between nitric oxide and EDRF.

Authors:  C J Long; K Shikano; B A Berkowitz
Journal:  Eur J Pharmacol       Date:  1987-10-13       Impact factor: 4.432

3.  Generation of superoxide free radical during the autoxidation of thiols.

Authors:  H P Misra
Journal:  J Biol Chem       Date:  1974-04-10       Impact factor: 5.157

4.  Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols.

Authors:  E A Kowaluk; H L Fung
Journal:  J Pharmacol Exp Ther       Date:  1990-12       Impact factor: 4.030

5.  Inhibition of endothelium-dependent vasorelaxation by arginine analogues: a pharmacological analysis of agonist and tissue dependence.

Authors:  G R Martin; M L Bolofo; H Giles
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

6.  Chemical oxidation of N-hydroxyguanidine compounds. Release of nitric oxide, nitroxyl and possible relationship to the mechanism of biological nitric oxide generation.

Authors:  J M Fukuto; G C Wallace; R Hszieh; G Chaudhuri
Journal:  Biochem Pharmacol       Date:  1992-02-04       Impact factor: 5.858

7.  The production of free radicals during the autoxidation of cysteine and their effect on isolated rat hepatocytes.

Authors:  G Saez; P J Thornalley; H A Hill; R Hems; J V Bannister
Journal:  Biochim Biophys Acta       Date:  1982-10-28

8.  Alterations in pharmacological receptor activities of rabbit arteries by sulfhydryl reagents.

Authors:  M Asano; H Hidaka
Journal:  Jpn J Pharmacol       Date:  1983-02

9.  L-cysteine augments the vasorelaxation induced by sodium nitrite and SIN-1 but not that due to acetylcholine.

Authors:  P Arvola; I Pörsti; P Vuorinen; H Huhtala; T Metsä-Ketelä; H Vapaatalo
Journal:  Eur J Pharmacol       Date:  1992-04-22       Impact factor: 4.432

10.  Release and properties of endothelium-derived relaxing factor (EDRF) from endothelial cells in culture.

Authors:  T M Cocks; J A Angus; J H Campbell; G R Campbell
Journal:  J Cell Physiol       Date:  1985-06       Impact factor: 6.384

View more
  28 in total

Review 1.  NO and the vasculature: where does it come from and what does it do?

Authors:  Karen L Andrews; Chris R Triggle; Anthie Ellis
Journal:  Heart Fail Rev       Date:  2002-10       Impact factor: 4.214

2.  A novel role for HNO in local and spreading vasodilatation in rat mesenteric resistance arteries.

Authors:  Kathryn H Yuill; Polina Yarova; Barbara K Kemp-Harper; Christopher J Garland; Kim A Dora
Journal:  Antioxid Redox Signal       Date:  2010-10-07       Impact factor: 8.401

3.  The shy Angeli and his elusive creature: the HNO route to vasodilation.

Authors:  Nazareno Paolocci; David A Wink
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-03-13       Impact factor: 4.733

Review 4.  A recent history of nitroxyl chemistry, pharmacology and therapeutic potential.

Authors:  Jon M Fukuto
Journal:  Br J Pharmacol       Date:  2018-07-01       Impact factor: 8.739

5.  Vasoactive actions of nitroxyl (HNO) are preserved in resistance arteries in diabetes.

Authors:  Marianne Tare; Rushita S R Kalidindi; Kristen J Bubb; Helena C Parkington; Wee-Ming Boon; Xiang Li; Christopher G Sobey; Grant R Drummond; Rebecca H Ritchie; Barbara K Kemp-Harper
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-01-10       Impact factor: 3.000

6.  Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide?

Authors:  M Y Ali; C Y Ping; Y-Yp Mok; L Ling; M Whiteman; M Bhatia; P K Moore
Journal:  Br J Pharmacol       Date:  2006-10-03       Impact factor: 8.739

7.  Analysis of the HNO and NO donating properties of alicyclic amine diazeniumdiolates.

Authors:  Gaurav Bharadwaj; Patricia G Z Benini; Debashree Basudhar; Cyf N Ramos-Colon; Gail M Johnson; Marti M Larriva; Larry K Keefer; Daniela Andrei; Katrina M Miranda
Journal:  Nitric Oxide       Date:  2014-09-02       Impact factor: 4.427

Review 8.  Endothelium-derived hyperpolarising factors and associated pathways: a synopsis.

Authors:  Gillian Edwards; Michel Félétou; Arthur H Weston
Journal:  Pflugers Arch       Date:  2010-04-11       Impact factor: 3.657

Review 9.  Therapeutic Potential of Nitroxyl (HNO) Donors in the Management of Acute Decompensated Heart Failure.

Authors:  Barbara K Kemp-Harper; John D Horowitz; Rebecca H Ritchie
Journal:  Drugs       Date:  2016-09       Impact factor: 9.546

10.  The effects of nitroxyl (HNO) on soluble guanylate cyclase activity: interactions at ferrous heme and cysteine thiols.

Authors:  Thomas W Miller; Melisa M Cherney; Andrea J Lee; Nestor E Francoleon; Patrick J Farmer; S Bruce King; Adrian J Hobbs; Katrina M Miranda; Judith N Burstyn; Jon M Fukuto
Journal:  J Biol Chem       Date:  2009-06-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.